Psychiatry and Clinical Psychopharmacology aims to publish studies of the highest scientific and clinical value, and encourages the submission of high-quality research that advances the understanding scientific fields such as psychiatry, child and adolescent  psychiatry, neurology, psychology, basic sciences (physiology, molecular psychiatry, pharmacology, genetics, etc.), clinical psychopharmacology, experimental psychopharmacology, basic and clinical neuroscience, neuroimaging, artificial intelligence  and machine learning, digital mental health, neuronal networks, psychiatric nursing, epidemiology, and public mental health.

The target audience of the journal includes specialists, residents, and scientists in psychiatry, psychology, neurology, neuroscience, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related disciplines.